tirzepatide to semaglutide What Are the Side Effects of vs. Semaglutide? Tirzepatide vs. Semaglutide: What's the

It is now targeted as an obesity treatment, with positive data from the SURMOUNT clinical trial program already published and further results pending

Second, we assessed each drug in expanded populations reflective of patients routinely seen in clinical practice

Both generally start at 2.5 mg once weekly and may increase gradually in 2.5 mg steps

Its worth noting that the US FDA allows these uses for Semaglutide: Type 2 Diabetes in Adults Weight Management in Obese or Overweight Adults Major Cardiovascular Events in Adults with Cardiovascular Disease and Obesity or Overweight Additionally, a study addressed the Semaglutide side effects, with 98.1% of patients experiencing mild-to-moderate gastrointestinal (GI) events in severity

Some users remain at 10 mg long-term without needing further escalation